BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Nagarajan P, Mahesh Kumar MJ, Venkatesan R, Majundar SS, Juyal RC. Genetically modified mouse models for the study of nonalcoholic fatty liver disease. World J Gastroenterol 2012; 18(11): 1141-1153 [PMID: 22468076 DOI: 10.3748/wjg.v18.i11.1141]
URL: https://www.wjgnet.com/1007-9327/full/v18/i11/1141.htm
Number Citing Articles
1
Sunaina Gautam, C.G. Agarwal, Monisha Banerjee. Study of CI962235 (Ins1361A), rs3212018 (16 bp del) and rs1049673 (G>C) CD36 Gene Polymorphisms in T2DM Patients of North IndiaJournal of Medical Sciences 2013; 13(6): 439 doi: 10.3923/jms.2013.439.445
2
Elika Safar Zadeh, Andreea O. Lungu, Elaine K. Cochran, Rebecca J. Brown, Marc G. Ghany, Theo Heller, David E. Kleiner, Phillip Gorden. The liver diseases of lipodystrophy: The long-term effect of leptin treatmentJournal of Hepatology 2013; 59(1): 131 doi: 10.1016/j.jhep.2013.02.007
3
Nisreen Soufi, Angela M. Hall, Zhouji Chen, Jun Yoshino, Sara L. Collier, James C. Mathews, Elizabeth M. Brunt, Carolyn J. Albert, Mark J. Graham, David A. Ford, Brian N. Finck. Inhibiting Monoacylglycerol Acyltransferase 1 Ameliorates Hepatic Metabolic Abnormalities but Not Inflammation and Injury in MiceJournal of Biological Chemistry 2014; 289(43): 30177 doi: 10.1074/jbc.M114.595850
4
Liza Dewyse, Hendrik Reynaert, Leo A. van Grunsven. Best Practices and Progress in Precision-Cut Liver Slice CulturesInternational Journal of Molecular Sciences 2021; 22(13): 7137 doi: 10.3390/ijms22137137
5
Mikheil Gogiashvili, Karolina Edlund, Kathrin Gianmoena, Rosemarie Marchan, Alexander Brik, Jan T. Andersson, Jörg Lambert, Katrin Madjar, Birte Hellwig, Jörg Rahnenführer, Jan G. Hengstler, Roland Hergenröder, Cristina Cadenas. Metabolic profiling of ob/ob mouse fatty liver using HR-MAS 1H-NMR combined with gene expression analysis reveals alterations in betaine metabolism and the transsulfuration pathwayAnalytical and Bioanalytical Chemistry 2017; 409(6): 1591 doi: 10.1007/s00216-016-0100-1
6
R. E. Patterson, A. S. Kirpich, J. P. Koelmel, S. Kalavalapalli, A. M. Morse, K. Cusi, N. E. Sunny, L. M. McIntyre, T. J. Garrett, R. A. Yost. Improved experimental data processing for UHPLC–HRMS/MS lipidomics applied to nonalcoholic fatty liver diseaseMetabolomics 2017; 13(11) doi: 10.1007/s11306-017-1280-1
7
Melina Ribeiro Fernandes, Priscila Silva Figueiredo, Karoline Silva Rezende, Karine de Cássia Freitas, Priscila Aiko Hiane, Rita de Cássia Avellaneda Guimarães. Experimental Animal Models of Human Diseases - An Effective Therapeutic Strategy2018;  doi: 10.5772/intechopen.72707
8
Dimitrios G Bouzianas, Stella D Bouziana, Apostolos I Hatzitolios. Potential treatment of human nonalcoholic fatty liver disease with long-chain omega-3 polyunsaturated fatty acidsNutrition Reviews 2013; 71(11): 753 doi: 10.1111/nure.12073
9
Jake P. Mann, Robert K. Semple, Matthew J. Armstrong. How Useful Are Monogenic Rodent Models for the Study of Human Non-Alcoholic Fatty Liver Disease?Frontiers in Endocrinology 2016; 7 doi: 10.3389/fendo.2016.00145
10
Beichu Guo, Zihai Li. Endoplasmic reticulum stress in hepatic steatosis and inflammatory bowel diseasesFrontiers in Genetics 2014; 5 doi: 10.3389/fgene.2014.00242
11
Christoph G Dietrich, Oliver Götze, Andreas Geier. Molecular changes in hepatic metabolism and transport in cirrhosis and their functional importanceWorld Journal of Gastroenterology 2016; 22(1): 72-88 doi: 10.3748/wjg.v22.i1.72
12
Yao Zhao, Yingjie Yu, Hong Li, Mingying Li, Dongran Zhang, Dandan Guo, Xiaohui Yu, Ce Lu, Hui Wang. The Association between Metabolic Syndrome and Biochemical Markers in Beijing AdolescentsInternational Journal of Environmental Research and Public Health 2019; 16(22): 4557 doi: 10.3390/ijerph16224557
13
Shailendra Arindkar, Jashdeep Bhattacharjee, Jerald Mahesh Kumar, Barun Das, Pramod Upadhyay, Shajahan Asif, Ramesh C Juyal, Subeer S Majumdar, Nagarajan Perumal. Antigen peptide transporter 1 is involved in the development of fructose-induced hepatic steatosis in miceJournal of Gastroenterology and Hepatology 2013; 28(8): 1403 doi: 10.1111/jgh.12186
14
Jesse D. Riordan, Joseph H. Nadeau. Modeling progressive non-alcoholic fatty liver disease in the laboratory mouseMammalian Genome 2014; 25(9-10): 473 doi: 10.1007/s00335-014-9521-3
15
Darkiane Fernandes Ferreira, Jarlei Fiamoncini, Iryna Hirata Prist, Suely Kubo Ariga, Heraldo Possolo de Souza, Thais Martins de Lima. Novel role of TLR4 in NAFLD development: Modulation of metabolic enzymes expressionBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2015; 1851(10): 1353 doi: 10.1016/j.bbalip.2015.07.002
16
Tong-shuo Zhang, Hua-lei Qin, Tong Wang, Hai-tao Li, Hai Li, Shi-hai Xia, Xiao-hui Xiang. Global publication trends and research hotspots of nonalcoholic fatty liver disease: a bibliometric analysis and systematic reviewSpringerPlus 2015; 4(1) doi: 10.1186/s40064-015-1542-1
17
Manoj Amrutkar, Emmelie Cansby, Esther Nuñez‐Durán, Carlo Pirazzi, Marcus Ståhlman, Elin Stenfeldt, Ulf Smith, Jan Borén, Margit Mahlapuu. Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASHThe FASEB Journal 2015; 29(4): 1564 doi: 10.1096/fj.14-264937
18
Gene P. Ables. Update on Ppar and Nonalcoholic Fatty Liver DiseasePPAR Research 2012; 2012: 1 doi: 10.1155/2012/912351
19
Jashdeep Bhattacharjee, Jerald Mahesh Kumar, Shailendra Arindkar, Barun Das, Upadhyay Pramod, Ramesh C. Juyal, Subeer S. Majumdar, Perumal Nagarajan. Role of immunodeficient animal models in the development of fructose induced NAFLDThe Journal of Nutritional Biochemistry 2014; 25(2): 219 doi: 10.1016/j.jnutbio.2013.10.010
20
Yoshihisa Takahashi, Yurie Soejima, Toshio Fukusato. Integrative Weight Management2014; : 61 doi: 10.1007/978-1-4939-0548-5_6
21
Yan Liu, Christoph Meyer, Chengfu Xu, Honglei Weng, Claus Hellerbrand, Peter ten Dijke, Steven Dooley. Animal models of chronic liver diseasesAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2013; 304(5): G449 doi: 10.1152/ajpgi.00199.2012
22
Laura Vera-Ramirez, Patricia Pérez-Lopez, Alfonso Varela-Lopez, MCarmen Ramirez-Tortosa, Maurizio Battino, José L. Quiles. Curcumin and liver diseaseBioFactors 2013; 39(1): 88 doi: 10.1002/biof.1057
23
Theodore Karatzas, Nikolaos Sikalias, Dimitrios Mantas, Apostolos Papalois, Konstantinos Alexiou, Lamprini Mountzalia, Gregory Kouraklis. Histopathological changes and onset of severe hepatic steatosis in rats fed a choline‑free dietExperimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.6385
24
Kazuo Nakamoto, Shogo Tokuyama. Involvement of the Free Fatty Acid Receptor GPR120/FFAR4 in the Development of Nonalcoholic SteatohepatitisYAKUGAKU ZASSHI 2019; 139(9): 1169 doi: 10.1248/yakushi.19-00011-4
25
Tsutomu Wada, Yusuke Miyashita, Motohiro Sasaki, Yusuke Aruga, Yuto Nakamura, Yoko Ishii, Masakiyo Sasahara, Keizo Kanasaki, Munehiro Kitada, Daisuke Koya, Hitoshi Shimano, Hiroshi Tsuneki, Toshiyasu Sasaoka. Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose dietAmerican Journal of Physiology-Endocrinology and Metabolism 2013; 305(11): E1415 doi: 10.1152/ajpendo.00419.2013
26
Brian J. DeBosch, Zhouji Chen, Jessica L. Saben, Brian N. Finck, Kelle H. Moley. Glucose Transporter 8 (GLUT8) Mediates Fructose-induced de Novo Lipogenesis and MacrosteatosisJournal of Biological Chemistry 2014; 289(16): 10989 doi: 10.1074/jbc.M113.527002
27
Ravirajsinh Jadeja, Ranjitsinh V. Devkar, Srinivas Nammi. Herbal Medicines for the Treatment of Nonalcoholic Steatohepatitis: Current Scenario and Future ProspectsEvidence-Based Complementary and Alternative Medicine 2014; 2014: 1 doi: 10.1155/2014/648308
28
Yoshitaka Kondo, Akihito Ishigami. Involvement of senescence marker protein-30 in glucose metabolism disorder and non-alcoholic fatty liver diseaseGeriatrics & Gerontology International 2016; 16: 4 doi: 10.1111/ggi.12722
29
Marica Cariello, Elena Piccinin, Antonio Moschetta. Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear Receptors PPARs, FXR, and LXR in NASHCellular and Molecular Gastroenterology and Hepatology 2021; 11(5): 1519 doi: 10.1016/j.jcmgh.2021.01.012
30
JINKYUNG CHO, SHINUK KIM, SHINHO LEE, HYUNSIK KANG. Effect of Training Intensity on Nonalcoholic Fatty Liver DiseaseMedicine & Science in Sports & Exercise 2015; 47(8): 1624 doi: 10.1249/MSS.0000000000000595
31
Bregje Van De Wier, Ger H. Koek, Aalt Bast, Guido R. M. M. Haenen. The potential of flavonoids in the treatment of non-alcoholic fatty liver diseaseCritical Reviews in Food Science and Nutrition 2017; 57(4): 834 doi: 10.1080/10408398.2014.952399
32
Hayato Nakagawa. Recent advances in mouse models of obesity- and nonalcoholic steatohepatitis-associated hepatocarcinogenesisWorld Journal of Hepatology 2015; 7(17): 2110-2118 doi: 10.4254/wjh.v7.i17.2110
33
Soraya Hölper, Hendrik Nolte, Eva Bober, Thomas Braun, Marcus Krüger. Dissection of metabolic pathways in the Db/Db mouse model by integrative proteome and acetylome analysisMolecular BioSystems 2015; 11(3): 908 doi: 10.1039/C4MB00490F
34
Yoshinori Marunaka. The Proposal of Molecular Mechanisms of Weak Organic Acids Intake-Induced Improvement of Insulin Resistance in Diabetes Mellitus via Elevation of Interstitial Fluid pHInternational Journal of Molecular Sciences 2018; 19(10): 3244 doi: 10.3390/ijms19103244
35
Sanja Stojsavljević, Marija Gomerčić Palčić, Lucija Virović Jukić, Lea Smirčić Duvnjak, Marko Duvnjak. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver diseaseWorld Journal of Gastroenterology 2014; 20(48): 18070-18091 doi: 10.3748/wjg.v20.i48.18070
36
Yoichi Asaoka, Shuji Terai, Isao Sakaida, Hiroshi Nishina. The expanding role of fish models in understanding non-alcoholic fatty liver diseaseDisease Models & Mechanisms 2013;  doi: 10.1242/dmm.011981
37
Hong Xu, Yang Zhou, Yongxia Liu, Jian Ping, Qiyang Shou, Fangming Chen, Ru Ruo. Metformin improves hepatic IRS2/PI3K/Akt signaling in insulin-resistant rats of NASH and cirrhosisJournal of Endocrinology 2016; 229(2): 133 doi: 10.1530/JOE-15-0409
38
Charlotte J. Green, Camilla Pramfalk, Karl J. Morten, Leanne Hodson. From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitationsAmerican Journal of Physiology-Endocrinology and Metabolism 2015; 308(1): E1 doi: 10.1152/ajpendo.00192.2014
39
D. T. Reid, B. Eksteen. Murine models provide insight to the development of non-alcoholic fatty liver diseaseNutrition Research Reviews 2015; 28(2): 133 doi: 10.1017/S0954422415000128
40
Xiang-lan Wei, Xiao-qing Chen, Ru-tang Fang, Xiao-yan Sun, Chang-sheng Zhu, Jie Yang, Xin Xue, Qiang Wang. Preventive Effects of Flavonoid Extracts from Ilex hainanensisMerr. on Rats with Hepatic Steatosis Induced by a High-Fat DietDrug Development Research 2012; 73(6): 308 doi: 10.1002/ddr.21014